1-9 of 9
Jan Dirk Studt
Close
Save search
Sort by
Journal Articles

Daratumumab for Refractory and Frequently Relapsing Immune Thrombotic Thrombocytopenic Purpura - a Case Series with Long-Term Follow-up

Free
Roman R. Schimmer, Jana Van Den Berg, Marissa Schraner, Alice Trinchero, Andreas Holbro, Johanna A. Kremer Hovinga, Jan-Dirk Studt
Journal: Blood
Blood (2024) 144 (Supplement 1): 4003.
https://doi.org/10.1182/blood-2024-208584
Published: 2024
Journal Articles

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Free
Alicia Rovo, MD, Thomas Daikeler, MD, Joerg Halter, MD, Dominik Heim, MD, Jan Dirk Studt, MD, Michael Medinger, MD, Caroline Arber, MD, Martin Stern, MD, Dimitrios Tsakiris, MD, Alan Tyndall, MD, Alois Gratwohl, MD, Andre Tichelli, MD
Journal: Blood
Blood (2008) 112 (11): 4298.
https://doi.org/10.1182/blood.V112.11.4298.4298
Published: 2008
Journal Articles

Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis

Free
Alicia Rovó, Thomas Daikeler, Martin Stern, Jörg Halter, Jan Dirk Studt, Andreas Buser, Dominik Heim, Johannes Rischewski, Michael Medinger, Alan Tyndall, Alois Gratwohl, André Tichelli
Journal: Blood
Blood (2008) 111 (3): 1740–1741.
https://doi.org/10.1182/blood-2007-10-115964
Published: 2008
Journal Articles

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Free
Clinical Trials & Observations Brief Report
Jan-Dirk Studt, Johanna A. Kremer Hovinga, Gerhard Antoine, Martin Hermann, Manfred Rieger, Friedrich Scheiflinger, Bernhard Lämmle
Journal: Blood
Blood (2005) 105 (2): 542–544.
https://doi.org/10.1182/blood-2004-06-2096
Published: 2005
Journal Articles

Factor V Leiden Is Not a Risk Factor for Thrombotic Microangiopathies without Severe ADAMTS13 Deficiency.

Free
Johanna A. Kremer Hovinga, MD, Soraya Krieg, MD, Jan-Dirk Studt, MD, Irmela Sulzer, Bernhard Lammle, MD
Journal: Blood
Blood (2004) 104 (11): 850.
https://doi.org/10.1182/blood.V104.11.850.850
Published: 2004
Journal Articles

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Free
Clinical Trials & Observations
Christoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, Friedrich Dorner, Bernhard Lämmle, Pier Mannuccio Mannucci, Friedrich Scheiflinger
Journal: Blood
Blood (2004) 103 (12): 4514–4519.
https://doi.org/10.1182/blood-2003-12-4165
Published: 2004
Journal Articles

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Free
Clinical Trials & Observations Brief Report
Jan-Dirk Studt, Johanna A. Kremer Hovinga, Radovan Radonic, Vladimir Gasparovic, Dragutin Ivanovic, Marijan Merkler, Urs Wirthmueller, Clemens Dahinden, Miha Furlan, Bernhard Lämmle
Journal: Blood
Blood (2004) 103 (11): 4195–4197.
https://doi.org/10.1182/blood-2003-11-3888
Published: 2004
Journal Articles

Discrepant activity levels of von Willebrand factor–cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura

Free
Jan-Dirk Studt, Johanna A. Kremer Hovinga, Miha Furlan, Bernhard Lämmle
Journal: Blood
Blood (2003) 102 (3): 1148.
https://doi.org/10.1182/blood-2003-05-1466
Published: 2003
Journal Articles

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Free
Clinical Trials & Observations
Sara K. Vesely, James N. George, Bernhard Lämmle, Jan-Dirk Studt, Lorenzo Alberio, Mayez A. El-Harake, Gary E. Raskob
Journal: Blood
Blood (2003) 102 (1): 60–68.
https://doi.org/10.1182/blood-2003-01-0193
Published: 2003